214 related articles for article (PubMed ID: 31663302)
1. Newer therapeutic approaches towards the management of diabetes mellitus: an update.
Lin HL; Mohamed Shukri FN; Yih ES; Sha GH; Jing GS; Jin GW; Hoong CW; Ying CQ; Panda BP; Candasamy M; Bhattamisra SK
Panminerva Med; 2023 Sep; 65(3):362-375. PubMed ID: 31663302
[TBL] [Abstract][Full Text] [Related]
2. Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.
Tiwari P
J Diabetes Res; 2015; 2015():340838. PubMed ID: 26273667
[TBL] [Abstract][Full Text] [Related]
3. Novel Approaches to Control Diabetes.
Dmello MM; Bhagwat G
Curr Diabetes Rev; 2024; 20(5):e090823219599. PubMed ID: 37559237
[TBL] [Abstract][Full Text] [Related]
4. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus: new drugs for a new epidemic.
Nicholson G; Hall GM
Br J Anaesth; 2011 Jul; 107(1):65-73. PubMed ID: 21610015
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches.
Prasathkumar M; Becky R; Anisha S; Dhrisya C; Sadhasivam S
Biotechnol Lett; 2022 Feb; 44(2):203-238. PubMed ID: 35119572
[TBL] [Abstract][Full Text] [Related]
10. [Hospital diabetes management (Update 2023)].
Mader JK; Brix JM; Aberer F; Vonbank A; Resl M; Hochfellner DA; Ress C; Pieber TR; Stechemesser L; Sourij H
Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):242-255. PubMed ID: 37101046
[TBL] [Abstract][Full Text] [Related]
11. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological management of type 2 diabetes mellitus: an update.
El-Kaissi S; Sherbeeni S
Curr Diabetes Rev; 2011 Nov; 7(6):392-405. PubMed ID: 21846326
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology Advanced Strategies for the Management of Diabetes Mellitus.
Mohsen AM
Curr Drug Targets; 2019; 20(10):995-1007. PubMed ID: 30848199
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapies for diabetes management: an update for the practicing clinician.
Meneghini L; Hirsch IB
Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
[TBL] [Abstract][Full Text] [Related]
15. Review of current and emerging therapies in type 2 diabetes mellitus.
Mazzola N
Am J Manag Care; 2012 Jan; 18(1 Suppl):S17-26. PubMed ID: 22559854
[TBL] [Abstract][Full Text] [Related]
16. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925
[TBL] [Abstract][Full Text] [Related]
17. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy.
Vinik A
Clin Ther; 2007 Jun; 29(6 Pt 1):1236-53. PubMed ID: 18036387
[TBL] [Abstract][Full Text] [Related]
18. Recent developments and emerging therapies for type 2 diabetes mellitus.
Evans AJ; Krentz AJ
Drugs R D; 1999 Aug; 2(2):75-94. PubMed ID: 10820647
[TBL] [Abstract][Full Text] [Related]
19. [Hospital diabetes management (Update 2019)].
Mader JK; Brix J; Aberer F; Vonbank A; Resl M; Pieber TR; Stechemesser L; Sourij H
Wien Klin Wochenschr; 2019 May; 131(Suppl 1):200-211. PubMed ID: 30980162
[TBL] [Abstract][Full Text] [Related]
20. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
Nadeau DA
Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
